Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and chiniofon

3,4-dihydroxyphenylacetic acid has been researched along with chiniofon in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fridkin, M; Gal, S; Youdim, MB; Zheng, H1
Amit, T; Golko-Perez, S; Kupershmidt, L; Mandel, S; Weinreb, O; Youdim, MB1

Other Studies

2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and chiniofon

ArticleYear
Restoration of nigrostriatal dopamine neurons in post-MPTP treatment by the novel multifunctional brain-permeable iron chelator-monoamine oxidase inhibitor drug, M30.
    Neurotoxicity research, 2010, Volume: 17, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Brain Chemistry; Cell Division; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Electrochemistry; Homovanillic Acid; Hydroxyquinolines; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neurons; Receptors, Transferrin; Serotonin; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase

2010
Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis.
    Neurotoxicity research, 2016, Volume: 29, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Amyotrophic Lateral Sclerosis; Animals; Biogenic Monoamines; Corpus Striatum; Diet; Disease Models, Animal; Hydroxyquinolines; Iron Chelating Agents; Male; Mice; Mice, Transgenic; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motor Activity; Neuroprotective Agents; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phenylacetates; Superoxide Dismutase; Superoxide Dismutase-1; Survival Analysis; Transcription Factors

2016